PCN6 Matching-Adjusted Indirect Treatment Comparisons (MAIC) of the Effect of Lorlatinib Versus Chemotherapy on Overall Survival (OS) and Progression-Free Survival (PFS) for Patients with Second-LINE or Later Anaplastic Lymphoma Kinase (ALK ...
Abstract
Authors
S. Smith F. Albuquerque de Almeida M. Inês L. Iadeluca M. Cooper